Ildong Holdings Co., Ltd. (KRX:000230)
South Korea · Delayed Price · Currency is KRW 8,510.00
-50.00 (-0.58%)
At close: Aug 18, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Medicine Manufacturing and Sales | 613.67B | Log In | Log In | Log In | Log In | Upgrade |
Medicine Manufacturing and Sales Growth | 2.21% | Log In | Log In | Log In | Log In | Upgrade |
Health Functional Food | 19.72B | Log In | Log In | Log In | Log In | Upgrade |
Health Functional Food Growth | 58.37% | Log In | Log In | Log In | Log In | Upgrade |
Cosmetic Medical Devices and Software Development | 12.69B | Log In | Log In | Log In | Log In | Upgrade |
Cosmetic Medical Devices and Software Development Growth | 26.37% | Log In | Log In | Log In | Log In | Upgrade |
Advertising Agency | 4.08B | Log In | Log In | Log In | Log In | Upgrade |
Advertising Agency Growth | -37.69% | Log In | Log In | Log In | Log In | Upgrade |
Ion Water Purifier | 3.20B | Log In | Log In | Log In | Log In | Upgrade |
Ion Water Purifier Growth | -27.80% | Log In | Log In | Log In | Log In | Upgrade |
Clinical Pharmacology Consulting | 2.77B | Log In | Log In | Log In | Log In | Upgrade |
Clinical Pharmacology Consulting Growth | -10.07% | Log In | Log In | Log In | Log In | Upgrade |
Holding Company | 1.46B | Log In | Log In | Log In | Log In | Upgrade |
Holding Company Growth | 11.09% | Log In | Log In | Log In | Log In | Upgrade |
Medical Platform Service Delivery | - | Log In | Log In | Log In | Log In | Upgrade |
Medical Platform Service Delivery Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Software Development | - | Log In | Log In | Log In | Log In | Upgrade |
Software Development Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Medical Device | - | Log In | Log In | Log In | Log In | Upgrade |
Medical Device Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Hyaluronic Acid and Filler | - | Log In | Log In | Log In | Log In | Upgrade |
Hyaluronic Acid and Filler Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
South Korea | 639.05B | Log In | Log In | Log In | Log In | Upgrade |
South Korea Growth | 2.33% | Log In | Log In | Log In | Log In | Upgrade |
Southeast Asia | 3.52B | Log In | Log In | Log In | Log In | Upgrade |
Japan | 2.24B | Log In | Log In | Log In | Log In | Upgrade |
Japan Growth | -40.57% | Log In | Log In | Log In | Log In | Upgrade |
Other | 11.87B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 26.50% | Log In | Log In | Log In | Log In | Upgrade |